In vitro mutagenicity of anti-inflammatory parsalmide analogues PA7, PA10, and PA31 triggered by biotransformation into hydroxy derivatives (original) (raw)

Purified prostaglandin synthase activates aromatic amines to derivatives that are mutagenic to Salmonella typhimurium

Denis Callewaert

Mutation Research Letters, 1992

View PDFchevron_right

Mutagenicity of selected polycyclic aromatic hydrocarbons (PAHs)

Emmanuel Awulu

Journal of Cell Biology and Genetics

View PDFchevron_right

Mutagenicity studies of p-substituted benzyl derivatives in the Ames Salmonella plate-incorporation assay

James Ball

Mutation Research/Genetic Toxicology, 1984

View PDFchevron_right

DNA BINDING AND MUTAGENICITY OF 7-SUBSTITUTED DERIVATIVES OF BENZ[A]ANTHRACENE

Joseph Wettstein

View PDFchevron_right

Mutagenicity Studies of Benzidine and Its Analogs: Structure-Activity Relationships

Ssu-Ching Chen

Toxicological Sciences, 2000

View PDFchevron_right

Mutagenicity studies of α,α′-dihalomethylbenzenes, α-methylbenzyl halides, and 1-chloromethylpyrene in the Ames assay

James Ball

Mutation Research Letters, 1987

View PDFchevron_right

Using base-specific Salmonella tester strains to characterize the types of mutation induced by benzidine and benzidine congeners after reductive metabolism

Larry D Claxton

Food and Chemical Toxicology, 2001

View PDFchevron_right

Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay

Nicholas Billinton, Richard Walmsley

Mutagenesis, 2008

View PDFchevron_right

Chemical purity and mutagenicity: Case study of a drug in development

Jeffrey Theiss

Mutation Research Letters, 1992

View PDFchevron_right

Importance of multiple hydroxylated metabolites in hexamethylphosphoramide (HMPA)-mediated mutagenesis in Drosophila melanogaster

Arne Van Der Gen

Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 1989

View PDFchevron_right

Selective activation of some dihydrodiols of several polycyclic aromatic hydrocarbons to mutagenic products by prostaglandin synthetase

Iain Robertson

Cancer Research, 1982

View PDFchevron_right

Mutagenicity studies on paracetamol in human volunteers II. Unscheduled DNA synthesis and micronucleus test

Radim Šrám

Mutation Research Letters, 1989

View PDFchevron_right

Mutagenic Study of Benzimidazole Derivatives with (+S9) and without (−S9) Metabolic Activation

Rozaini Abdullah

International Journal of Molecular Sciences, 2019

View PDFchevron_right

Mutagenicity of phenanthrene and phenanthrene K-region derivatives

David Avnir

Mutation research, 1979

View PDFchevron_right

Bacterial Mutagenesis and Cell Transformation Assays of Pyrvinium Pamoate (Povan), An Antiparasitic Agent

Felix de la Iglesia

Journal of the American College of Toxicology, 1984

View PDFchevron_right

4-Monochlorobiphenyl (PCB3) induces mutations in the livers of transgenic Fisher 344 rats

Gabriele Ludewig

Carcinogenesis, 2007

View PDFchevron_right

Development and validation of alternative metabolic systems for mutagenicity testing in short-term assays

J. Rueff, Montserrat Llagostera

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1996

View PDFchevron_right

An investigation of the mutagenic activity of salamide – a major impurity of hydrochlorothiazide

Ismet çok

Toxicology Mechanisms and Methods, 2016

View PDFchevron_right

Mutagenicity Testing of 9-N-Substituted Adenines and Their N-Oxidation Products

Costas Ioannides

Environmental Health Perspectives, 1993

View PDFchevron_right

Assessing the potential of pharmaceuticals and their transformation products to cause mutagenic effects: Implications for gene expression profiling

Evroula Hapeshi

Environmental Toxicology and Chemistry, 2016

View PDFchevron_right

A Novel Strategy to Predict Carcinogenicity of Antiparasitics Based on a Combination of DNA Lesions and Bacterial Mutagenicity Tests

Dr. Awais Ihsan

Frontiers in public health, 2017

View PDFchevron_right

The dosing determines mutagenicity of hydrophobic compounds in the Ames II assay with metabolic transformation: Passive dosing versus solvent spiking

Minne Heringa

Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2013

View PDFchevron_right

The Mutagenic Potential of 3 , 5-Dimethylaminophenol in Bacterial and Mammalian Cells

pinar erkekoglu

2017

View PDFchevron_right

Steric effects on the direct mutagenicity of N-acyloxy-N-alkoxyamides—Probes for drug–DNA interactions

Stephen Glover

Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2011

View PDFchevron_right

Comparative analysis of mutagenic potency of 1-nitro-acridine derivatives

Priyanka Tiwari

Life Sciences, 2005

View PDFchevron_right

Relative mutagenicity and teratogenicity of cyclophosphamide and two of its structural analogs

Barbara Hales

Biochemical Pharmacology, 1983

View PDFchevron_right

Mutation research/fundamental and molecular mechanisms of mutagenesis

Miroslav Dostál

Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2013

View PDFchevron_right

The relationship between frameshift mutagenicity and DNA-binding affinity in a series of acridine-substituted derivatives of the experimental antitumour drug 4′-(9-acridinylamino)methanesulphonanilide (AMSA)

B. Baguley

Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

View PDFchevron_right

Mutagenesis by the (+)-anti-diol epoxide of benzo[a]pyrene: What controls mutagenic specificity?

Henry Rodriguez

Biochemistry, 1993

View PDFchevron_right

Absence of in vivo mutagenicity of 4,4'-oxybis(benzenesulfonohydrazide) in liver and glandular stomach of MutaTM Mouse

yasumasa murata

Fundamental Toxicological Sciences

View PDFchevron_right

Biotransformations Leading to Toxic Metabolites

Patrick Dansette

The Practice of Medicinal Chemistry, 2008

View PDFchevron_right

Prediction of PAH mutagenicity in human cells by QSAR classification1

Paola Gramatica

SAR and QSAR in Environmental Research, 2008

View PDFchevron_right

Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein

Barbara Hales

Cancer research, 1982

View PDFchevron_right